Traders Buy Shares of Allstate (ALL) on Weakness

Traders bought shares of Allstate (NYSE:ALL) on weakness during trading hours on Friday. $50.03 million flowed into the stock on the tick-up and $13.30 million flowed out of the stock on the tick-down, for a money net flow of $36.73 million into the stock. Of all equities tracked, Allstate had the 17th highest net in-flow for the day. Allstate traded down ($0.39) for the day and closed at $96.36

A number of research analysts have recently commented on ALL shares. Keefe, Bruyette & Woods lowered Allstate from a “market perform” rating to an “underperform” rating in a report on Tuesday, January 2nd. Zacks Investment Research lowered Allstate from a “buy” rating to a “hold” rating in a report on Tuesday, March 6th. Morgan Stanley reissued an “equal weight” rating and set a $105.00 price objective (down previously from $113.00) on shares of Allstate in a report on Wednesday, February 21st. Wells Fargo lowered Allstate from an “outperform” rating to a “market perform” rating in a report on Tuesday, January 9th. Finally, Argus reaffirmed a “buy” rating and issued a $110.00 target price on shares of Allstate in a report on Wednesday, February 21st. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and six have assigned a buy rating to the company’s stock. Allstate presently has a consensus rating of “Hold” and an average target price of $100.40.

How to Become a New Pot Stock Millionaire

The firm has a market cap of $34,293.82, a PE ratio of 14.36, a P/E/G ratio of 1.38 and a beta of 0.94. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.31.

Allstate (NYSE:ALL) last released its earnings results on Wednesday, February 7th. The insurance provider reported $2.09 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.53 by $0.56. Allstate had a return on equity of 12.57% and a net margin of 8.28%. The firm had revenue of $8.20 billion for the quarter, compared to analyst estimates of $8.09 billion. During the same quarter last year, the firm posted $2.17 EPS. The company’s revenue was up 3.8% on a year-over-year basis. equities research analysts predict that Allstate will post 8.41 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Monday, April 2nd. Stockholders of record on Monday, March 5th were issued a dividend of $0.46 per share. This represents a $1.84 annualized dividend and a dividend yield of 1.91%. The ex-dividend date was Friday, March 2nd. This is a positive change from Allstate’s previous quarterly dividend of $0.37. Allstate’s dividend payout ratio (DPR) is presently 27.42%.

Several large investors have recently made changes to their positions in ALL. Cambridge Investment Research Advisors Inc. lifted its position in shares of Allstate by 3.2% during the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 54,205 shares of the insurance provider’s stock worth $5,676,000 after buying an additional 1,699 shares during the period. Wagner Wealth Management LLC bought a new position in shares of Allstate during the 4th quarter worth approximately $894,000. Xact Kapitalforvaltning AB lifted its position in shares of Allstate by 8.1% during the 4th quarter. Xact Kapitalforvaltning AB now owns 52,346 shares of the insurance provider’s stock worth $5,481,000 after buying an additional 3,912 shares during the period. Massmutual Trust Co. FSB ADV lifted its position in shares of Allstate by 929.2% during the 4th quarter. Massmutual Trust Co. FSB ADV now owns 89,126 shares of the insurance provider’s stock worth $6,364,000 after buying an additional 80,466 shares during the period. Finally, CNB Bank bought a new position in shares of Allstate during the 4th quarter worth approximately $429,000. 77.89% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION WARNING: “Traders Buy Shares of Allstate (ALL) on Weakness” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international trademark and copyright legislation. The legal version of this article can be read at https://www.dispatchtribunal.com/2018/04/15/traders-buy-shares-of-allstate-all-on-weakness.html.

About Allstate

The Allstate Corporation, together with its subsidiaries, engages in property and casualty insurance, and life insurance businesses in the United States and Canada. The company's Allstate Protection segment sells private passenger auto and homeowners insurance; specialty auto products, including motorcycle, trailer, motor home, and off-road vehicle insurance policies; other personal lines products, including renter, condominium, landlord, boat, umbrella, and manufactured home insurance policies; and commercial lines products under the Allstate, Esurance, and Encompass brand names.

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply